Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2001
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Age Factors (MeSH)
- Aged (MeSH)
- Antibodies, Monoclonal (MeSH)
- Antibodies, Monoclonal, Murine-Derived (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Clinical Trials, Phase II as Topic (MeSH)
- Comorbidity (MeSH)
- Cyclophosphamide (MeSH)
- Disease-Free Survival (MeSH)
- Doxorubicin (MeSH)
- Female (MeSH)
- Granulocyte Colony-Stimulating Factor (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Lymphoma, Non-Hodgkin (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Neutropenia (MeSH)
- Prednisone (MeSH)
- Prognosis (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Rituximab (MeSH)
- Survival Rate (MeSH)
- Vincristine (MeSH)
published in
- Annals of Hematology Journal